TY - JOUR AU - Mall, M. A. AU - Hartl, D. PY - 2014 DA - 2014// TI - CFTR: cystic fibrosis and beyond JO - Eur Respir J VL - 44 UR - https://doi.org/10.1183/09031936.00228013 DO - 10.1183/09031936.00228013 ID - Mall2014 ER - TY - JOUR AU - Lund-Palau, H. AU - Turnbull, A. R. AU - Bush, A. AU - Bardin, E. AU - Cameron, L. AU - Soren, O. PY - 2016 DA - 2016// TI - Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches JO - Expert Rev Respir Med VL - 10 UR - https://doi.org/10.1080/17476348.2016.1177460 DO - 10.1080/17476348.2016.1177460 ID - Lund-Palau2016 ER - TY - JOUR AU - Mayer-Hamblett, N. AU - Kloster, M. AU - Rosenfeld, M. AU - Gibson, R. L. AU - Retsch-Bogart, G. Z. AU - Emerson, J. PY - 2015 DA - 2015// TI - Impact of sustained eradication of new Pseudomonas aeruginosa infection on long-term outcomes in cystic fibrosis JO - Clin Infect Dis VL - 61 UR - https://doi.org/10.1093/cid/civ377 DO - 10.1093/cid/civ377 ID - Mayer-Hamblett2015 ER - TY - STD TI - Report CFFPRAD. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf Accessed 22 May 2019. UR - https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf ID - ref4 ER - TY - JOUR AU - Stefani, S. AU - Campana, S. AU - Cariani, L. AU - Carnovale, V. AU - Colombo, C. AU - Lleo, M. M. PY - 2017 DA - 2017// TI - Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis JO - Int J Med Microbiol VL - 307 UR - https://doi.org/10.1016/j.ijmm.2017.07.004 DO - 10.1016/j.ijmm.2017.07.004 ID - Stefani2017 ER - TY - JOUR AU - Chalmers, J. D. PY - 2017 DA - 2017// TI - Macrolide resistance in Pseudomonas aeruginosa: implications for practice JO - Eur Respir J. VL - 49 UR - https://doi.org/10.1183/13993003.00689-2017 DO - 10.1183/13993003.00689-2017 ID - Chalmers2017 ER - TY - JOUR AU - Mogayzel, P. J. AU - Naureckas, E. T. AU - Robinson, K. A. AU - Mueller, G. AU - Hadjiliadis, D. AU - Hoag, J. B. PY - 2013 DA - 2013// TI - Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health JO - Am J Respir Crit Care Med VL - 187 UR - https://doi.org/10.1164/rccm.201207-1160OE DO - 10.1164/rccm.201207-1160OE ID - Mogayzel2013 ER - TY - JOUR AU - Principi, N. AU - Blasi, F. AU - Esposito, S. PY - 2015 DA - 2015// TI - Azithromycin use in patients with cystic fibrosis JO - Eur J Clin Microbiol Infect Dis VL - 34 UR - https://doi.org/10.1007/s10096-015-2347-4 DO - 10.1007/s10096-015-2347-4 ID - Principi2015 ER - TY - JOUR AU - Saiman, L. AU - Marshall, B. C. AU - Mayer-Hamblett, N. AU - Burns, J. L. AU - Quittner, A. L. AU - Cibene, D. A. PY - 2003 DA - 2003// TI - Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial JO - JAMA. VL - 290 UR - https://doi.org/10.1001/jama.290.13.1749 DO - 10.1001/jama.290.13.1749 ID - Saiman2003 ER - TY - JOUR AU - Imperi, F. AU - Leoni, L. AU - Visca, P. PY - 2014 DA - 2014// TI - Antivirulence activity of azithromycin in Pseudomonas aeruginosa JO - Front Microbiol VL - 5 UR - https://doi.org/10.3389/fmicb.2014.00178 DO - 10.3389/fmicb.2014.00178 ID - Imperi2014 ER - TY - JOUR AU - Buyck, J. M. AU - Plesiat, P. AU - Traore, H. AU - Vanderbist, F. AU - Tulkens, P. M. AU - Bambeke, F. PY - 2012 DA - 2012// TI - Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis473 DO - 10.1093/cid/cis473 ID - Buyck2012 ER - TY - JOUR AU - Mustafa, M. -. H. AU - Khandekar, S. AU - Tunney, M. M. PY - 2017 DA - 2017// TI - Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients JO - Eur Respir J VL - 49 UR - https://doi.org/10.1183/13993003.01847-2016 DO - 10.1183/13993003.01847-2016 ID - Mustafa2017 ER - TY - JOUR AU - Palmer, K. L. AU - Aye, L. M. AU - Whiteley, M. PY - 2007 DA - 2007// TI - Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum JO - J Bacteriol VL - 189 UR - https://doi.org/10.1128/JB.01138-07 DO - 10.1128/JB.01138-07 ID - Palmer2007 ER - TY - STD TI - Hogardt MH, Susanne; Balke, Beate; Kahl, Barbara C.; Schmoldt, Sabine; Leitritz, Lorenz; Jäger, Gundula; Kappler, Matthias; Suerbaum, Sebastian; Heesemann, Jürgen Atemwegsinfektionen bei Mukoviszidose. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik 2006;MiQ24. ID - ref14 ER - TY - JOUR AU - Matuschek, E. AU - Ahman, J. AU - Webster, C. AU - Kahlmeter, G. PY - 2018 DA - 2018// TI - Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp JO - Clin Microbiol Infect VL - 24 UR - https://doi.org/10.1016/j.cmi.2017.11.020 DO - 10.1016/j.cmi.2017.11.020 ID - Matuschek2018 ER - TY - JOUR AU - Balouiri, M. AU - Sadiki, M. AU - Ibnsouda, S. K. PY - 2016 DA - 2016// TI - Methods for in vitro evaluating antimicrobial activity: a review JO - J Pharm Anal VL - 6 UR - https://doi.org/10.1016/j.jpha.2015.11.005 DO - 10.1016/j.jpha.2015.11.005 ID - Balouiri2016 ER - TY - JOUR AU - Wiegand, I. AU - Hilpert, K. AU - Hancock, R. E. PY - 2008 DA - 2008// TI - Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances JO - Nat Protoc VL - 3 UR - https://doi.org/10.1038/nprot.2007.521 DO - 10.1038/nprot.2007.521 ID - Wiegand2008 ER - TY - JOUR AU - Oberhardt, M. A. AU - Puchalka, J. AU - Fryer, K. E. AU - Martins dos Santos, V. A. AU - Papin, J. A. PY - 2008 DA - 2008// TI - Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1 JO - J Bacteriol VL - 190 UR - https://doi.org/10.1128/JB.01583-07 DO - 10.1128/JB.01583-07 ID - Oberhardt2008 ER - TY - JOUR AU - Pressler, T. AU - Bohmova, C. AU - Conway, S. AU - Dumcius, S. AU - Hjelte, L. AU - Hoiby, N. PY - 2011 DA - 2011// TI - Chronic Pseudomonas aeruginosa infection definition: EuroCareCF working group report JO - J Cyst Fibros VL - 10 UR - https://doi.org/10.1016/S1569-1993(11)60011-8 DO - 10.1016/S1569-1993(11)60011-8 ID - Pressler2011 ER - TY - JOUR AU - Marvig, R. L. AU - Sondergaard, M. S. AU - Damkiaer, S. AU - Hoiby, N. AU - Johansen, H. K. AU - Molin, S. PY - 2012 DA - 2012// TI - Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.00630-12 DO - 10.1128/AAC.00630-12 ID - Marvig2012 ER - TY - JOUR AU - Castellani, C. AU - Duff, A. J. A. AU - Bell, S. C. AU - Heijerman, H. G. M. AU - Munck, A. AU - Ratjen, F. PY - 2018 DA - 2018// TI - ECFS best practice guidelines: the 2018 revision JO - J Cyst Fibros VL - 17 UR - https://doi.org/10.1016/j.jcf.2018.02.006 DO - 10.1016/j.jcf.2018.02.006 ID - Castellani2018 ER - TY - JOUR AU - Molinari, G. AU - Guzman, C. A. AU - Pesce, A. AU - Schito, G. C. PY - 1993 DA - 1993// TI - Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics JO - J Antimicrob Chemother VL - 31 UR - https://doi.org/10.1093/jac/31.5.681 DO - 10.1093/jac/31.5.681 ID - Molinari1993 ER - TY - JOUR AU - Diaz Iglesias, Y. AU - Wilms, T. AU - Vanbever, R. AU - Bambeke, F. PY - 2019 DA - 2019// TI - Activity of antibiotics against Staphylococcus aureus in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium JO - Antimicrob Agents Chemother. VL - 63 UR - https://doi.org/10.1128/AAC.00602-19 DO - 10.1128/AAC.00602-19 ID - Diaz Iglesias2019 ER - TY - JOUR AU - Swatton, J. E. AU - Davenport, P. W. AU - Maunders, E. A. AU - Griffin, J. L. AU - Lilley, K. S. AU - Welch, M. PY - 2016 DA - 2016// TI - Impact of azithromycin on the quorum sensing-controlled proteome of Pseudomonas aeruginosa JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0147698 DO - 10.1371/journal.pone.0147698 ID - Swatton2016 ER - TY - JOUR AU - Godeke, J. AU - Pustelny, C. AU - Haussler, S. PY - 2013 DA - 2013// TI - Recycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.02582-12 DO - 10.1128/AAC.02582-12 ID - Godeke2013 ER - TY - JOUR AU - Scoffone, V. C. AU - Trespidi, G. AU - Chiarelli, L. R. AU - Barbieri, G. AU - Buroni, S. PY - 2019 DA - 2019// TI - Quorum sensing as antivirulence target in cystic fibrosis pathogens JO - Int J Mol Sci VL - 20 UR - https://doi.org/10.3390/ijms20081838 DO - 10.3390/ijms20081838 ID - Scoffone2019 ER - TY - JOUR AU - Kariminik, A. AU - Baseri-Salehi, M. AU - Kheirkhah, B. PY - 2017 DA - 2017// TI - Pseudomonas aeruginosa quorum sensing modulates immune responses: an updated review article JO - Immunol Lett VL - 190 UR - https://doi.org/10.1016/j.imlet.2017.07.002 DO - 10.1016/j.imlet.2017.07.002 ID - Kariminik2017 ER - TY - JOUR AU - Saiman, L. AU - Anstead, M. AU - Mayer-Hamblett, N. AU - Lands, L. C. AU - Kloster, M. AU - Hocevar-Trnka, J. PY - 2010 DA - 2010// TI - Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial JO - JAMA. VL - 303 UR - https://doi.org/10.1001/jama.2010.563 DO - 10.1001/jama.2010.563 ID - Saiman2010 ER -